Clinical Trials Directory

Trials / Unknown

UnknownNCT03530007

Anti-shivering Effect of Ondansetron

Comparison Between Two Different Doses of Ondansetron on the Incidence of Spinal Shivering During Cesarean Section

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Shivering is one of the most frequent complications occurring during or after spinal anesthesia with many side effects. The aim of the present study was to compare between two different doses of ondansetron for anti-shivering effect

Detailed description

Shivering is one of the most frequent complications occurring during or after spinal anesthesia, it affects about 40%-60 % of patients under spinal anesthesia. Intra and Post spinal shivering is distressing for the patients and anesthetist. Shivering may aggravate medical conditions in patients with limited cardiac or respiratory functions. It increases tissue oxygen demand many folds which in turn leads to increase the load on respiratory and cardiac systems to cope with increased aerobic metabolism. Shivering interferes with good patient monitoring by causing artifacts of electrocardiography, invasive and non-invasive blood pressure, pulse oximetry, etc... . Postoperatively shivering may cause discomfort to the patient, increases wound pain by stretching incision, increase the incidence of bleeding and infection. We aim to compare the prophylactic use of two different doses of ondansetron on the incidence of shivering after spinal anesthesia in patients scheduled for lower limb surgery. The primary outcome was percentage of patients suffering from shivering after spinal anesthesia, secondary outcomes include any side effects related to both doses.

Conditions

Interventions

TypeNameDescription
DRUGNormal salinenormal saline used for prevention of spinal shivering
DRUGOndansetron 4 MGondansetron 4 MG used for prevention of spinal shivering
DRUGOndansetron 8mgondansetron 8 MG used for prevention of spinal shivering

Timeline

Start date
2018-05-15
Primary completion
2018-08-15
Completion
2018-09-15
First posted
2018-05-21
Last updated
2018-05-21

Source: ClinicalTrials.gov record NCT03530007. Inclusion in this directory is not an endorsement.